# Reasoning trace

## Question interpreted

The requested held-out target file contains one gene, `Pdss1`. I interpreted the task as asking for a point prediction of the focal endpoint:

`n_degs = count of measured genes with pvals_adj < 0.05 in 151 TH Prkcd Grin2c Glut cells after acute AAV CRISPR loss of the requested target`.

`Pdss1` is completely absent from the supplied training DEG count CSV and from the supplied differential-expression Parquet, so the requested endpoint is directly observed for training perturbations but absent for `Pdss1`. I therefore treated training perturbations in the same assay as the central quantitative evidence and used external biology only to decide which training targets are mechanistically relevant. I did not use target-mRNA knockdown as an editing-efficiency score because the dataset portrait says self-knockdown is not correlated with downstream effect size in this experiment.

## Sources used

- Declared focal training counts: `../../../../../inputs/holdout/151_TH_Prkcd_Grin2c_Glut_deg_counts_training.csv`.
- Declared DE Parquet: `training differential-expression dataset`, filtered to `group_name == "151 TH Prkcd Grin2c Glut"` for focal expression-pattern checks.
- Requested-target CSV: `single-target request for Pdss1`.
- Dataset portrait and measurement registry in `codex_runtime/pipeline/`, which define the perturbation as sparse postnatal mouse neuronal CRISPR loss of function and the Parquet as single-nucleus differential-expression summaries among recovered nuclei.
- Internal same-experiment semantic corpus: PerturbAI July 260713 sourceguard-1773 corpus v1, release `perturbai-july-260713-sourceguard-1773-v1`. I used only the `Coq5` packaged findings and evidence because `Coq5` is the only represented CoQ-biosynthesis target.
- External biology:
  - Nguyen et al. 2014, DOI `10.1016/j.bbalip.2014.08.007`: human `COQ5` is an inner-mitochondrial CoQ C-methyltransferase that can act in the CoQ biosynthetic complex.
  - Yen et al. 2020, DOI `10.1016/j.bbabio.2020.148192`: multiple human PDSS/COQ proteins participate in mitochondrial complexes and PDSS/COQ perturbation can reduce CoQ10.
  - Desbats et al. 2014, DOI `10.1007/s10545-014-9749-9`, and Salviati et al., GeneReviews `Primary Coenzyme Q10 Deficiency Overview`, updated 2023: primary CoQ10 deficiency can be caused by defects in PDSS/COQ biosynthetic genes and reflects loss of mitochondrial ubiquinone functions, including electron transport.
  - Malicdan et al. 2018, DOI `10.1002/humu.23345`, and Nardecchia et al. 2020, DOI `10.1002/acn3.51232`: pathogenic variants in COQ5 or PDSS1 cause primary CoQ10-deficiency syndromes with neurologic phenotypes.
  - Fessler et al. 2020, DOI `10.1038/s41586-020-2076-4`, and Sasaki et al. 2020, DOI `10.1042/BSR20201289`: mitochondrial damage can reach the nuclear integrated-stress response through the OMA1-DELE1-HRI/eIF2alpha-ATF4 axis, making ATF4/CHOP-class transcripts plausible stress readouts if a CoQ perturbation were strong enough.

## Computation over the declared dataset

The requested CSV had one row, `Pdss1`. The training count table had 1,674 perturbations; 1,205 were zero, 276 had exactly one DEG, and 1,512 had at most two DEGs, so a zero count is common but not automatic.

I next looked for direct CoQ-biosynthesis and mitochondrial analogs in the 1,674 training targets. Among `Pdss%`, `Coq%`, and the former `Adck%`/COQ8 class, only `Coq5` was present, with `n_degs = 0` in the focal cell group. Other ubiquinone-linked or respiratory comparators were also nearly silent in `151 TH Prkcd Grin2c Glut`:

| training target | focal `n_degs` | relationship to `Pdss1` |
| --- | ---: | --- |
| `Coq5` | 0 | same CoQ biosynthetic pathway, downstream aromatic-ring C-methyltransferase |
| `Uqcrb` | 0 | respiratory complex III subunit, receives electrons from ubiquinol |
| `Uqcrfs1` | 0 | respiratory complex III Rieske subunit, receives electrons from ubiquinol |
| `Uqcrc2` | 1 | respiratory complex III core protein |
| `Cyc1` | 1 | respiratory complex III cytochrome c1 subunit |
| `Ndufs2` | 1 | complex I subunit upstream of ubiquinone reduction |
| `Ndufc2` | 1 | complex I subunit upstream of ubiquinone reduction |
| `Cox5a` | 1 | complex IV respiratory-chain subunit, downstream of complex III |
| `Ndufa10` | 1 | complex I subunit upstream of ubiquinone reduction |
| `Clpp` | 0 | mitochondrial matrix protease, stress/proteostasis comparator |
| `Lonp1` | 0 | mitochondrial protease, stress/proteostasis comparator in the focal group |
| `Opa1` | 37 | mitochondrial inner-membrane fusion/cristae gene; positive but mechanistically less direct |

For the focal Parquet rows, I queried `Coq5` and these mitochondrial comparators, counted their FDR < 0.05 genes, and pivoted Wilcoxon `scores` by measured gene to compare expression patterns. In `Coq5`, there were 200 perturbed and 23,679 matched control nuclei in the focal group; no gene reached FDR 0.05 and the strongest nominal downstream hit, `Ei24`, still had adjusted P = 1.0. Targeted mitochondrial ISR or UPR-related genes were also absent in the focal `Coq5` profile: `Atf4`, `Ddit3`, `Trib3`, `Herpud1`, `Asns`, `Shmt2`, `Aldh1l2`, `Mthfd2`, `Lonp1`, `Hspd1`, `Hspa5`, and `Clpp` all had `pvals_adj = 1.0`.

The focal score-vector correlations with `Coq5` were near zero rather than forming a hidden mitochondrial expression state: `Opa1` r = 0.0322, `Ndufa10` r = 0.0247, `Lonp1` r = 0.0186, `Uqcrb` r = 0.0137, `Cyc1` r = 0.0089, `Uqcrfs1` r = 0.0083, `Clpp` r = 0.0074, `Cox5a` r = 0.0065, `Ndufs2` r = 0.0062, `Uqcrc2` r = -0.0076, and `Ndufc2` r = -0.0119. This expression-pattern check is important because it argues against using a large response from an unrelated high-DEG gene as a proxy for `Pdss1`; the direct CoQ analog itself is dominated by null signal in this assay.

The same-experiment `Coq5` report in the PerturbAI July corpus agrees with the direct Parquet read. Its finding `Coq5:F001` states that all 22 recovered neuronal groups assayed for `Coq5` had zero downstream genes at FDR < 0.10. `Coq5:F002` specifically checked expected ATF4/CHOP and mitochondrial stress genes and found them absent after `Coq5`, while noting that the same pipeline did detect `Atf4`, `Ddit3`, `Herpud1`, `Shmt2`, `Hspd1`, and `Clpp` after other perturbations. `Coq5:F003` reported that literature-obvious ubiquinone and mitochondrial stress comparators, including `Uqcrfs1`, `Uqcrc2`, `Cyc1`, `Uqcrb`, `Ndufs2`, `Ndufc2`, `Clpp`, and `Lonp1`, had score-space Pearson correlations of only approximately 0.0015 to 0.0187 against `Coq5` across matched groups.

## Target-specific transfer: `Pdss1`

Biologically, `Pdss1` is part of the PDSS1/PDSS2 decaprenyl-diphosphate synthase that produces the polyisoprenoid side chain for coenzyme Q, whereas `Coq5` is a later C-methyltransferase in CoQ ring modification. Loss of either activity should reduce the CoQ pool and can produce primary CoQ10 deficiency in humans, but they are not obligate subunits of the same heteromeric enzyme. Thus `Coq5` is the closest assayed pathway analog, not an exact complex-subunit substitute.

The causal transfer chain I used was:

`Pdss1` CRISPR loss -> impaired CoQ side-chain synthesis -> lower ubiquinone availability and possible complex I/II to complex III electron-transfer stress -> postnatal thalamic-glutamatergic neuronal survivor-state transcription -> FDR-thresholded snRNA-seq DEGs.

The strongest same-assay observation on that chain is that weakening the same CoQ biosynthetic pathway through `Coq5` did not produce a focal or pan-neuronal nuclear RNA response. If `Pdss1` loss created a sufficiently large early CoQ defect in recovered juvenile neurons, a mitochondrial ISR or broad OXPHOS-stress state would be a plausible endpoint; the observed `Coq5` profile did not show that state, and nearby complex I/III/IV perturbations were also at 0 or 1 DEG in the focal group. `Opa1` is a counterexample showing that a mitochondrial gene can produce a nonzero signature in this cell group, but its 37-DEG response involves cristae/fusion biology rather than CoQ synthesis and its score vector was still only r = 0.032 with `Coq5`.

External knowledge slightly raises the prior that complete `PDSS1` loss can matter neurologically, because PDSS1 is upstream of all CoQ isoforms and pathogenic human variants cause sensory-neural or neurologic CoQ10-deficiency phenotypes. That evidence is a disease and biochemical prior, not a measurement in acutely edited recovered mouse thalamic neurons. It does not overcome the direct training observation that partial AAV CRISPR disruption of the only assayed CoQ-biosynthesis gene, plus several ubiquinone-linked respiratory-complex genes, was almost entirely buffered at the FDR 0.05 DEG-count endpoint.

I therefore finalized `Pdss1` as a zero-count prediction: biologically non-null CoQ metabolism, but no expected FDR-significant transcriptional breadth in this focal snRNA-seq contrast.

## Limits

The closest exact PDSS enzyme partner, `Pdss2`, and other CoQ synthome genes such as `Coq2`, `Coq3`, `Coq4`, `Coq6`, `Coq7`, `Coq8a`, `Coq8b`, `Coq9`, `Coq10a`, and `Coq10b` were absent from the training perturbation table, so the prediction rests on `Coq5` as a same-pathway analog rather than on a direct PDSS1/PDSS2 subunit comparison. The Parquet measures nuclear RNA among surviving recovered nuclei, not CoQ abundance, respiration, indel rate, or cell loss before harvest. A zero DEG count therefore means that I predict no genes to pass this assay's FDR threshold, not that `Pdss1` is dispensable or that CoQ biosynthesis was fully intact.
